The cytolethal distending toxin effects on mammalian cells: A DNA damage perspective

Cells

Volumn 3, Issue 2, 2014, Pages 592-615

  Bezine, Elisabeth ^a   Vignard, Julien ^a   Mirey, Gladys ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

Author keywords

Cell cycle checkpoints; Cytolethal distending toxin; DNA damage response; Double strand breaks; Gram negative bacteria; Replicative stress

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; ETOPOSIDE; NUCLEASE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL DEATH; CELL DIVISION; CELL VIABILITY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; GENETIC INSTABILITY; GENETIC PARAMETERS; INFLAMMATION; IONIZING RADIATION; MAMMAL CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PATHOGENICITY; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY;

EID: 84922022031     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3020592     Document Type: Review

References (125)

1. Johnson, W.M., Lior, H. Response of chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol. Lett. 1987, 43, 19-23.
2. Johnson, W.M., Lior, H. A new heat-labile Cytolethal Distending Toxin (CLDT) produced by campylobacter spp. Microbiol. Pathol. 1988, 4, 115-126.
3. Cope, L.D., Lumbley, S., Latimer, J.L., Klesney-Tait, J., Stevens, M.K., Johnson, L.S., Purven, M., Munson, R.S., Lagergard, T., Radolf, J.D., et al. A diffusible cytotoxin of haemophilus ducreyi. Proc. Natl. Acad. Sci. 1997, 94, 4056-4061.
4. Sugai, M., Kawamoto, T., Pérès, S.Y., Ueno, Y., Komatsuzawa, H., Fujiwara, T., Kurihara, H., Suginaka, H., Oswald, E. The cell cycle-specific growth-inhibitory factor produced by actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 1998, 66, 5008-5019.
5. Shen, Z., Feng, Y., Rogers, A.B., Rickman, B., Whary, M.T., Xu, S., Clapp, K.M., Boutin, S.R., Fox, J.G. Cytolethal distending toxin promotes helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect. Immun. 2009, 77, 2508-2516.
6. Haghjoo, E., Galán, J.E. Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc. Natl. Acad. Sci. 2004, 101, 4614-4619.
7. Stanley, J., Linton, D., Burnens, A.P., Dewhirst, F.E., On, S.L.W., Porter, A., Owen, R.J., Costas, M. Helicobacter pullorurn sp. nov.-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 1994, 140, 3441-3449.
8. Chien, C.C., Taylor, N.S., Ge, Z., Schauer, D.B., Young, V.B., Fox, J.G. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol. 2000, 49, 525-534.
9. Jinadasa, R.N., Bloom, S.E., Weiss, R.S., Duhamel, G.E. Cytolethal distending toxin: A conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 2011, 157, 1851-1875.
10. Nipic, D., Podlesek, Z., Budic, M., Crnigoj, M., Zgur-Bertok, D. Escherichia coli uropathogenic-specific protein, usp, is a bacteriocin-like genotoxin. J. Infect. Dis. 2013, 208, 1545-1552.
11. Nougayrède, J., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., Oswald, E. Escherichia coli induces dna double-strand breaks in eukaryotic cells. Science 2006, 313, 848-851.
12. Yamamoto, S., Nakano, M., Terai, A., Yuri, K., Nakata, K., Nair, G.B., Kurazono, H., Ogawa, O. The presence of the virulence island containing the usp gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J. Urol. 2001, 165, 1347-1351.
13. Arthur, J.C., Perez-chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., et al. Intestinal inflammation targets cancerinducing activity of the microbiota. Science 2012, 338, 120-123.
14. Finlay, B.B., Falkow, S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 1997, 61, 136-169.
15. Ge, Z., Schauer, D.B., Fox, J.G. In vivo virulence properties of bacterial Cytolethal Distending Toxin. Cell. Microbiol. 2008, 10, 1599-1607.
16. Jain, D., Prasad, K.N., Sinha, S., Husain, N. Differences in virulence attributes between cytolethal distending toxin positive and negative campylobacter jejuni strains. J. Med. Microbiol. 2008, 57, 267-272.
17. Pokkunuri, V., Pimentel, M., Morales, W., Jee, S.R., Alpern, J., Weitsman, S., Marsh, Z., Low, K., Hwang, L., Khoshini, R., et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J. Neurogastroenterol. Motil. 2012, 18, 434-442.
18. Ge, Z., Rogers, A.B., Feng, Y., Lee, A., Xu, S., Taylor, N.S., Fox, J.G. Bacterial cytolethal distending toxin promotes the development of dysplasia in a model of microbially induced hepatocarcinogenesis. Cell. Microbiol. 2007, 9, 2070-2080.
19. Song, J., Gao, X., Galán, J.E. Structure and function of the salmonella typhi chimaeric A2B5 typhoid toxin. Nature 2013, 499, 350-354.
20. Scott, D.A., Kaper, J.B. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect. Immun. 1994, 62, 244-251.
21. Pickett, C.L., Cottle, D.L., Pesci, E.C., Bikah, G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect. Immun. 1994, 62, 1046-1051.
22. Nesić, D., Hsu, Y., Stebbins, C.E. Assembly and function of a bacterial genotoxin. Nature 2004, 429, 429-433.
23. Yamada, T., Komoto, J., Saiki, K., Konishi, K., Takusagawa, F. Variation of loop sequence alters stability of cytolethal distending toxin (CDT): Crystal structure of CDT from actinobacillus actinomycetemcomitans. Protein Sci. 2006, 15, 362-372.
24. Spanò, S., Ugalde, J.E., Galán, J.E. Delivery of a salmonella typhi exotoxin from a host intracellular compartment. Cell Host Microbe 2008, 3, 30-38.
25. Kaslow, H.R., Burns, D.L. Pertussis toxin and target eukaryotic cells: Binding, entry, and activation. FASEB J. 1992, 6, 2685-2690.
26. Ueno, Y., Ohara, M., Kawamoto, T., Fujiwara, T., Komatsuzawa, H., Oswald, E., Sugai, M. Biogenesis of the actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect. Immun. 2006, 74, 3480-3487.
27. Zijnge, V., Kieselbach, T., Oscarsson, J. Proteomics of protein secretion by aggregatibacter actinomycetemcomitans. PLoS One 2012, 7, e41662.
28. Berlanda Scorza, F., Doro, F., Rodríguez-Ortega, M.J., Stella, M., Liberatori, S., Taddei, A.R., Serino, L., Gomes Moriel, D., Nesta, B., Fontana, M.R., et al. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli deltatolR IHE3034 mutant. Mol. Cell. Proteomics 2008, 7, 473-485.
29. Lindmark, B., Rompikuntal, P.K., Vaitkevicius, K., Song, T., Mizunoe, Y., Uhlin, B.E., Guerry, P., Wai, S.N. Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from campylobacter jejuni. BMC Microbiol. 2009, 9, 220.
30. Rompikuntal, P.K., Thay, B., Khan, M.K., Alanko, J., Penttinen, A.-M., Asikainen, S., Wai, S.N., Oscarsson, J. Perinuclear localization of internalized outer membrane vesicles carrying active cytolethal distending toxin from aggregatibacter actinomycetemcomitans. Infect. Immun. 2012, 80, 31-42.
31. Gargi, A., Reno, M., Blanke, S.R. Bacterial toxin modulation of the eukaryotic cell cycle: Are all cytolethal distending toxins created equally? Front. Cell. Infect. Microbiol. 2012, 2, 124.
32. Hu, X., Nesic, D., Stebbins, C.E. Comparative structure-function analysis of cytolethal distending toxins. Proteins 2006, 62, 421-434.
33. Lee, R.B., Hassane, D.C., Cottle, D.L., Pickett, C.L. Interactions of campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 2003, 71, 4883-4890.
34. Mcsweeney, L.A., Dreyfus, L.A. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect. Immun. 2005, 73, 2051-2060.
35. Eshraghi, A., Maldonado-arocho, F.J., Gargi, A., Cardwell, M.M., Prouty, M.G., Blanke, S.R., Bradley, K.A. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. Microbiology 2010, 285, 18199-18207.
36. Carette, J.E., Guimaraes, C.P., Varadarajan, M., Park, A.S., Wuethrich, I., Godarova, A., Kotecki, M., Cochran, B.H., Spooner, E., Ploegh, H.L., et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 2009, 326, 1231-1235.
37. Carette, J.E., Guimaraes, C.P., Wuethrich, I., Blomen, V.A., Sun, C., Bell, G., Yuan, B., Muellner, M.K., Nijman, M., Ploegh, H.L., et al. Global gene disruption in human cells to assign genes to phenotypes. Nat. Biotechnol. 2011, 29, 542-546.
38. Cortes-Bratti, X., Chaves-Olarte, E., Lagergård, T., Thelestam, M. Cellular Internalization of cytolethal distending toxin from haemophilus ducreyi. Infect. Immun. 2000, 68, 6903-6911.
39. Guerra, L., Teter, K., Lilley, B.N., Stenerlöw, B., Holmes, R.K., Ploegh, H.L., Sandvig, K., Thelestam, M., Frisan, T. Cellular internalization of cytolethal distending toxin: A new end to a known pathway. Cell. Microbiol. 2005, 7, 921-934.
40. Boesze-Battaglia, K., Besack, D., McKay, T., Zekavat, A., Otis, L., Jordan-Sciutto, K., Shenker, B.J. Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by actinobacillus actinomycetemcomitans cytolethal-distending toxin. Cell. Microbiol. 2006, 8, 823-836.
41. Boesze-Battaglia, K., Brown, A., Walker, L., Besack, D., Zekavat, A., Wrenn, S., Krummenacher, C., Shenker, B.J. cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J. Biol. Chem. 2009, 284, 10650-10658.
42. Lin, C.D., Lai, C.K., Lin, Y.H., Hsieh, J.T., Sing, Y.T., Chang, Y.C., Chen, K.C., Wang, W.C., Su, H.L., Lai, C.H. Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells. Infect. Immun. 2011, 79, 3563-3575.
43. Damek-Poprawa, M., Jang, J.Y., Volgina, A., Korostoff, J., DiRienzo, J.M. Localization of Aggregatibacter actinomycetemcomitans cytolethal distending toxin subunits during intoxication of live cells. Infect. Immun. 2012, 80, 2761-2770.
44. Lara-Tejero, M., Galàn, J.E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-Like protein. Science 2000, 290, 354-357.
45. Nishikubo, S., Ohara, M., Ueno, Y., Ikura, M., Kurihara, H., Komatsuzawa, H., Oswald, E., Sugai, M. Ann-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J. Biol. Chem. 2003, 278, 50671-50681.
46. Guerra, L., Nemec, K.N., Massey, S., Tatulian, S.A., Thelestam, M., Frisan, T., Teter, K. A novel mode of translocation for cytolethal distending toxin. Biochim. Biophys. Acta 2009, 1793, 489-495.
47. Gargi, A., Tamilselvam, B., Powers, B., Prouty, M.G., Lincecum, T., Eshraghi, A., Maldonado-Arocho, F.J., Wilson, B.A., Bradley, K.A., Blanke, S.R. Cellular interactions of the cytolethal distending toxins from Escherichia coli and haemophilus ducreyi. J. Biol. Chem. 2013, 288, 7492-7505.
48. McSweeney, L.A., Dreyfus, L.A. Nuclear localization of the Escherichia coli cytolethal Distending toxin CdtB subunit. Cell. Microbiol. 2004, 6, 447-458.
49. Pérès, S.Y., Marchès, O., Daigle, F., Nougayrède, J.P., Herault, F., Tasca, C., de Rycke, J., Oswald, E. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 1997, 24, 1095-1107.
50. Comayras, C., Tasca, C., Pe, S.Y., Oswald, E., Rycke, J.D.E. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G 2/M Tr. Infect. Immun. 1997, 65, 5088-5095.
51. Ohguchi, M., Ishisaki, A., Okahashi, N., Koide, M., Koseki, T., Yamato, K., Noguchi, T., Nishihara, T. Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis. Infect. Immun. 1998, 66, 5980-5987.
52. Sert, V., Cans, C., Tasca, C., Oswald, E., Ducommun, B., de Rycke, J. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 1999, 18, 6296-6304.
53. Fahrer, J., Huelsenbeck, J., Jaurich, H., Dörsam, B., Frisan, T., Eich, M., Roos, W.P., Kaina, B., Fritz, G. Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts. DNA Repair (Amst) 2014, 18, 31-43.
54. Elwell, C.A., Dreyfus, L.A. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 2000, 37, 952-963.
55. Niida, H., Nakanishi, M. DNA damage checkpoints in mammals. Mutagenesis 2006, 21, 3-9.
56. Jackson, S.P., Bartek, J. The DNA-damage response in human biology and disease. Nature 2009, 461, 1071-1078.
57. Lee, J.-H., Paull, T.T. ATM activation by DNA double-Strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005, 308, 551-554.
58. Rogakou, E.P., Boon, C., Redon, C., Bonner, W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 1999, 146, 905-916.
59. Zou, L., Elledge, S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300, 1542-1548.
60. Zhao, H., Piwnica-Worms, H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 2001, 21, 4129-4139.
61. Ward, I.M., Chen, J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 2001, 276, 47759-47762.
62. Matsuoka, S., Ballif, B.A; Smogorzewska, A., McDonald, E.R., Hurov, K.E., Luo, J., Bakalarski, C.E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316, 1160-1166.
63. Gobbini, E., Cesena, D., Galbiati, A., Lockhart, A., Longhese, M.P. Interplays between ATM/Tel1 and ATR/Mec1 in sensing and signaling DNA double-strand breaks. DNA Repair (Amst) 2013, 12, 791-799.
64. Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C.M., Lukas, J., Jackson, S.P. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 2006, 8, 37-45.
65. Feng, W., di Rienzi, S.C., Raghuraman, M.K., Brewer, B.J. Replication stress-induced chromosome breakage is correlated with replication fork progression and is preceded by single-stranded DNA formation. G3 Genes Genomes Genet. 2011, 1, 327-335.
66. Cortes-Bratti, X., Karlsson, C., Lagergård, T., Thelestam, M., Frisan, T. The haemophilus ducreyi cytolethal distending Toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J. Biol. Chem. 2001, 276, 5296-5302.
67. Li, L., Sharipo, A., Chaves-Olarte, E., Masucci, M.G., Levitsky, V., Thelestam, M., Frisan, T. The haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell. Microbiol. 2002, 4, 87-99.
68. Hassane, D.C., Lee, R.B., Pickett, C.L. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect. Immun. 2003, 71, 541-545.
69. Guerra, L., Albihn, A., Tronnersjö, S., Yan, Q., Guidi, R., Stenerlöw, B., Sterzenbach, T., Josenhans, C., Fox, J.G., Schauer, D.B., et al. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS One 2010, 5, e8924.
70. Alaoui-El-Azher, M., Mans, J.J., Baker, H.V; Chen, C., Progulske-Fox, A., Lamont, R.J., Handfield, M. Role of the ATM-checkpoint kinase 2 pathway in CDT-mediated apoptosis of gingival epithelial cells. PLoS One 2010, 5, e11714.
71. Bielaszewska, M., Sinha, B., Kuczlus, T., Karch, H. Cytolethal distending toxin from shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, Inhibition of proliferation, and Death of human endothelial cells. Infect. Immun. 2005, 73, 552-562.
72. Taieb, F., Nougayrède, J., Watrin, C., Samba-louaka, A., Oswald, E. Escherichia coli cyclomodulin Cif induces G 2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. 2006, 8, 1910-1921.
73. Blazkova, H., Krejcikova, K., Moudry, P., Frisan, T., Hodny, Z., Bartek, J. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J. Cell. Mol. Med. 2010, 14, 357-367.
74. Liyanage, N.P.M., Manthey, K.C., Dassanayake, R.P., Kuszynski, C.A., Oakley, G.G., Duhamel, G.E. Helicobacter hepaticus cytolethal distending toxin causes cell death in Intestinal epithelial cells via mitochondrial apoptotic pathway. Helicobacter 2010, 15, 98-107.
75. Fedor, Y., Vignard, J., Nicolau-Travers, M.-L., Boutet-Robinet, E., Watrin, C., Salles, B., Mirey, G. From single-strand breaks to double-strand breaks during S-phase: A new mode of action of the Escherichia coli cytolethal distending toxin. Cell. Microbiol. 2013, 15, 1-15.
76. Vignard, J., Mirey, G., Salles, B. Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up. Radiother. Oncol. 2013, 108, 362-369.
77. Ahn, J., Urist, M., Prives, C. The Chk2 protein kinase. DNA Repair (Amst) 2004, 3, 1039-1047.
78. Sato, T., Koseki, T., Yamato, K., Saiki, K., Konishi, K., Yoshikawa, M., Ishikawa, I., Nishihara, T. p53-Independent Expression of p21 CIP1/WAF1 in plasmacytic cells during G2 cell cycle arrest induced by actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2002, 70, 528-534.
79. Hochegger, H., Takeda, S., Hunt, T. Cyclin-dependent kinases and cell-cycle transitions: Does one fit all? Nat. Rev. Mol. Cell Biol. 2008, 9, 910-916.
80. Langerak, P., Russell, P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366, 3562-3571.
81. Alby, F., Mazars, R., de Rycke, J., Guillou, E., Baldin, V., Darbon, J.M., Ducommun, B. Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase. FEBS Lett. 2001, 491, 261-265.
82. De Rycke, J., Sert, V., Comayras, C., Tasca, C. Sequence of lethal events in HeLa cells exposed to the G2 blocking cytolethal distending toxin. Eur. J. Cell Biol. 2000, 79, 192-201.
83. Escalas, N., Davezac, N., de Rycke, J., Baldin, V., Mazars, R., Ducommun, B. Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: Involvement of the CDC25 phosphatase. Exp. Cell Res. 2000, 257, 206-212.
84. Bielaszewska, M., Fell, M., Greune, L., Prager, R., Fruth, A., Tschäpe, H., Schmidt, M.A., Karch, H., Tscha, H. Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 2004, 72, 1812-1816.
85. Cortes-Bratti, X., Frisan, T., Thelestam, M. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 2001, 39, 1729-1736.
86. Frisan, T., Cortes-bratti, X., Chaves-olarte, E., Stenerlöw, B., Thelestam, M., Rica, U.D.C., José, S., Rica, C. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell. Microbiol. 2003, 5, 695-707.
87. Abbas, T., Dutta, A. P21 in Cancer: Intricate networks and multiple activities. Nat. Rev. Cancer 2009, 9, 400-414.
88. Shenker, B.J., Hoffmaster, R.H., Zekavat, A., Yamaguchi, N., Lally, E.T., Demuth, D.R. Induction of apoptosis in human T cells by actinobacillus actinomycetemcomitans cytolethal distending toxin Is a consequence of G2 arrest of the cell cycle. J. Immunol. 2001, 167, 435-441.
89. Ohara, M., Hayashi, T., Kusunoki, Y., Miyauchi, M., Takata, T., Sugai, M., Mmun, I.N.I. Caspase-2 and Caspase-7 are involved in cytolethal distending toxin-induced apoptosis in jurkat and MOLT-4 T-cell lines. Infect. Immun. 2004, 72, 871-879.
90. Hickey, T.E., Majam, G., Guerry, P. Intracellular survival of campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect. Immun. 2005, 73, 5194-5197.
91. Guidi, R., Guerra, L., Levi, L., Stenerlöw, B., Fox, J.G., Josenhans, C., Masucci, M.G., Frisan, T. Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response. Cell. Microbiol. 2013, 15, 98-113.
92. Gelfanova, V., Hansen, E.J., Spinola, S.M. Cytolethal distending toxin of haemophilus ducreyi induces apoptotic death of jurkat T cells. Infect. Immun. 1999, 67, 6394-6402.
93. Wising, C., Azem, J., Zetterberg, M., Svensson, L.A., Ahlman, K., Lagerga, T. Induction of apoptosis/necrosis in various human cell lineages by haemophilus ducreyi cytolethal distending toxin. Toxicon 2005, 45, 767-776.
94. Shenker, B.J., Dlakic, M., Walker, L.P., Besack, D., Jaffe, E., LaBelle, E., Boesze-Battaglia, K. A novel mode of action for a microbial-derivated immunotoxin: The cytolethal distending toxin subunit B exhibits phosphatidylinositol3,4,5-triphosphate phosphatase activity. J. Immunol. 2007, 178, 5099-5108.
95. Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 2013, 75, 685-705.
96. Guerra, L., Guidi, R., Frisan, T. Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression? FEBS J. 2011, 278, 4577-4588.
97. Mao, X., DiRienzo, J.M. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 2002, 4, 245-255.
98. Hontz, J.S., Villar-Lecumberri, M.T., Dreyfus, L.A; Yoder, M.D. Crystallization of Escherichia coli CdtB, the biologically active subunit of cytolethal distending toxin. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2006, 62, 192-195.
99. Campbell, V.W., Jackson, D.A. The effect of divalent cations on the mode of action of DNase I. J. Biol. Chem. 1980, 255, 3726-3735.
100. Pan, C.Q., Ulmer, J.S., Herzka, A., Lazarus, R.A. Mutational analysis of human DNase I at the DNA binding interface: Implications for DNA recognition, catalysis, and metal ion dependence. Protein Sci. 1998, 7, 628-636.
101. 2+ -dependent neutral nuclease. FEMS Microbiol. Lett. 2005, 251, 219-225.
102. DiRienzo, J.M., Cao, L., Volgina, A., Bandelac, G., Korostoff, J. Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse. FEMS Microbiol. Lett. 2009, 291, 222-231.
103. Roots, R., Holley, W., Chatterjee, A., Rachal, E., Kraft, G. The influence of radiation quality on the formation of DNA breaks. Adv. Space Res. 1989, 9, 45-55.
104. Averbeck, D. Mécanismes de réparation et mutagenèse radio-induite chez les eucaryotes supérieurs. Cancer Radiother. 2000, 4, 335-354.
105. Collins, A.R., Oscoz, A.A., Brunborg, G., Gaivão, I., Giovannelli, L., Kruszewski, M., Smith, C.C., Stetina, R. The comet assay: Topical issues. Mutagenesis 2008, 23, 143-151.
106. Pommier, Y. Topoisomerase I inhibitors: Camptothecins and beyond. Nat. Rev. Cancer 2006, 6, 789-802.
107. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444, 638-642.
108. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V.F., Kolettas, E., Niforou, K., Zoumpourlis, V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444, 633-637.
109. Goodarzi, A.A., Jeggo, P.A. The repair and signaling responses to DNA double-strand breaks. Adv. Genet. 2013, 82, 1-45.
110. Bétermier, M., Bertrand, P., Lopez, B.S. Is non-homologous end-joining really an inherently error-prone process? PLoS Genet. 2014, 10, e1004086.
111. Aze, A., Zhou, J.C., Costa, A., Costanzo, V. DNA replication and homologous recombination factors: Acting together to maintain genome stability. Chromosoma 2013, 122, 401-413.
112. Amunugama, R., Fishel, R. Homologous Recombination in Eukaryotes, 1st ed., Elsevier Inc.: Amsterdam, The Netherlands, 2012; Volume 110, pp. 155-206.
113. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J.N., Ried, T., Tagle, D., et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 1996, 86, 159-171.
114. Takai, H., Naka, K., Okada, Y., Watanabe, M., Harada, N., Saito, S., Anderson, C.W., Appella, E., Nakanishi, M., Suzuki, H., et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 2002, 21, 5195-5205.
115. Matangkasombut, O., Wattanawaraporn, R., Tsuruda, K., Ohara, M., Sugai, M., Mongkolsuk, S. Cytolethal distending toxin from aggregatibacter actinomycetemcomitans induces DNA damage, S/G2 cell cycle arrest, and caspase-independent death in a saccharomyces cerevisiae model. Infect. Immun. 2010, 78, 783-792.
116. Kitagawa, T., Hoshida, H., Akada, R. Genome-wide analysis of cellular response to bacterial genotoxin CdtB in yeast. Infect. Immun. 2007, 75, 1393-1402.
117. Janssen, A., Medema, R.H. Genetic instability: Tipping the balance. Oncogene 2013, 32, 4459-4470.
118. Morrison, W.B. Inflammation and cancer: A comparative view. J. Vet. Intern. Med. 2012, 26, 18-31.
119. Grivennikov, S.I., Greten, F.R., Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 883-899.
120. Polk, D.B., Peek, R.M., Jr. Helicobacter pylori: Gastric cancer and beyond. Nat. Rev. Cancer 2010, 10, 403-414.
121. Machado, A.M., Fiqueiredo, C., Seruca, R., Rasmussen, L. Helicobacter pylori infection generates genetic instability in gastric cells. Biochim. Biophys. Acta 2010, 1806, 58-65.
122. Touati, E., Michel, V., Thiberge, J.M., Wuscher, N., Huerre, M., Labigne, A. Chronic helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003, 124, 1408-1419.
123. Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013, 14, 207-215.
124. Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G., Han, Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013, 14, 195-206.
125. Samaras, V., Rafailidis, P.I., Mourtzoukou, E.G., Peppas, G., Falagas, M.E. Chronic bacteria and parasitic infections and cancer: A review. J. Infect. Dev. Ctries. 2010, 4, 267-281.